1. Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical Validation
- Author
-
Torres A, Sierra M, Juan Carlos Ruiz-Rodríguez, M-Carmen Estévez, Ruiz-Sanmartín A, Maria Soler, Bueno l, López-Aladid R, Olalla Calvo-Lozano, fernandez-naval C, Ricard Ferrer, Laura M. Lechuga, Esperalba J, Juan José González-López, Chiscano-camon l, Fernández-Barat L, Coutard B, Charrel R, Attoumani S, Institut Català de la Salut, [Calvo-Lozano O, Sierra M, Soler M, Estévez MC] Nanobiosensors and Bioanalytical Applications Group (NanoB2A), Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC, CIBERBBN and BIST, Barcelona, Spain. [Chiscano-Camón L, Ruiz-Sanmartin A, Ruiz-Rodriguez JC, Ferrer R] Servei de Medicina Intensiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Shock, Disfunció Orgànica i Ressuscitació, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [González-López JJ] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Genètica i Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Esperalba J, Fernández-Naval C] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, European Commission, Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Ministerio de Economía y Competitividad (España), Generalitat de Catalunya, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación (España), Vall d'Hebron Research Institute, European Virus Archive Global, Fundació Glòria Soler, Consejo Superior de Investigaciones Científicas (España), Calvo-Lozano, Olalla, Soler, María, Estévez, M. Carmen, Lechuga, Laura M., Calvo-Lozano, Olalla [0000-0001-5486-2237], Soler, María [0000-0001-7232-2277], Estévez, M. Carmen [0000-0003-3694-7186], and Lechuga, Laura M. [0000-0001-5187-5358]
- Subjects
Coronavirus disease 2019 (COVID-19) ,Immunology ,Library science ,European Social Fund ,Peptides and proteins ,Biosensing Techniques ,Nucleocapside protein ,Antibodies, Viral ,COVID-19 (Malaltia) ,Sensitivity and Specificity ,Article ,Analytical Chemistry ,Assays ,03 medical and health sciences ,Biopolymers ,Political science ,virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES] ,aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos víricos [COMPUESTOS QUÍMICOS Y DROGAS] ,Humans ,European commission ,Pandemics ,Investigative Techniques::Molecular Probe Techniques::Biosensing Techniques [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,Label free ,030304 developmental biology ,0303 health sciences ,030306 microbiology ,Sensors ,Serological Test ,SARS-CoV-2 ,COVID-19 ,Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES] ,Surface Plasmon Resonance ,University hospital ,Biobank ,Receptor-binding domain (RBD) ,Clinical diagnosis ,técnicas de investigación::técnicas de sondas moleculares::técnicas biosensoras [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,Highly sensitive ,3. Good health ,Biosensors ,Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Viral [CHEMICALS AND DRUGS] ,Christian ministry ,Immunoglobulines - Abstract
Serological tests are essential for the control and management of COVID-19 pandemic (diagnostics and surveillance, and epidemiological and immunity studies). We introduce a direct serological biosensor assay employing proprietary technology based on plasmonics, which offers rapid (, ICN2 and UVE acknowledge financial support from H2020 Research and Innovation Programme of the European Commission (H202-SC1-PHE-Coronavirus-2020, CONVAT Project, No. 101003544). The ICN2 is funded by the CERCA program/Generalitat de Catalunya and supported by the Severo Ochoa Centres of Excellence program funded by the Spanish Research Agency (AEI, grant no. SEV-2017-0706). ICN2 group is very grateful to EPI Industries (Barcelona, Spain) for its kind donation supporting our research in COVID-19. O.C.-L. acknowledges the economic support from the Spanish Ministry of Science and Innovation and the Spanish Research Agency and the European Social Fund (ESF) (ref. BES-2017-080527) linked to the TEC 2016-78515-R project Predict. A part of the work was supported by the European Virus Archive GLOBAL (EVA-GLOBAL) project that has received funding from the EU Horizon 2020 (grant agreement No. 871029). A.T. and L.F.-B. acknowledge financial support from GENCAT-DGRIS COVID. We are indebted to all the patients who accepted to participate contributing to science advancement. We are indebted to the HCB-IDIBAPS Biobank for the human samples and data procurement and to the Fundació Glòria Soler for its support to the COVIDBANK collection. We thank the IDIBAPS Biobank for its valuable contribution to sample processing and storage. The authors acknowledge the EU Horizon 2020 Program under grant agreement no. 644956 (RAIS project) for funding the Hospital Vall d’Hebron Biobank. The VHIR-HUVH is supported by Plan Nacional de I + D + i 2013-2016 and ISCIII-Ministerio de Ciencia e Innovación, and Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003)─cofinanced by European Development Regional Fund “A way to achieve Europe,” Operative program Intelligent Growth 2014. Part of the samples and data from patients included in this study were provided by the Vall d’Hebron University Hospital Biobank (PT17/0015/0047), integrated in the Spanish National Biobanks Network, and they were processed following standard operating procedures with the appropriate approval of the Ethical and Scientific Committee. The authors kindly appreciate the generous donation of samples and clinical data of the donors of the Sepsis Bank of HUVH Biobank and COVID-19 patients attended at HUVH.
- Published
- 2022